Cargando…

Promising Molecular Targets for Pharmacological Therapy of Neurodegenerative Pathologies

Drug development for the treatment of neurodegenerative diseases has to confront numerous problems occurring, in particular, because of attempts to address only one of the causes of the pathogenesis of neurological disorders. Recent advances in multitarget therapy research are gaining momentum by ut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neganova, M. E., Aleksandrova, Yu. R., Nebogatikov, V. O., Klochkov, S. G., Ustyugov, A. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	A.I. Gordeyev 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604899/ https://www.ncbi.nlm.nih.gov/pubmed/33173597 http://dx.doi.org/10.32607/actanaturae.10925

Ejemplares similares

Deciphering the Mysterious Relationship between the Cross-Pathogenetic Mechanisms of Neurodegenerative and Oncological Diseases
por: Aleksandrova, Yulia, et al.
Publicado: (2023)

Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment
por: Neganova, Margarita, et al.
Publicado: (2021)

Unique indolizidine alkaloid securinine is a promising scaffold for the development of neuroprotective and antitumor drugs
por: Klochkov, Sergey, et al.
Publicado: (2021)

Cytoplasmic aggregation of mutant FUS causes multistep RNA splicing perturbations in the course of motor neuron pathology
por: Rezvykh, Alexander P, et al.
Publicado: (2023)

N-Alkylation of Anthracycline Antibiotics by Natural Sesquiterpene Lactones as a Way to Obtain Antitumor Agents with Reduced Side Effects
por: Neganova, Margarita, et al.
Publicado: (2021)

The Role of a Pathological Interaction between β-amyloid and Mitochondria in the Occurrence and Development of Alzheimer’s Disease
por: Nikolaeva, N. S., et al.
Publicado: (2022)

Promising Molecular Targets in Pharmacological Therapy for Neuronal Damage in Brain Injury
por: de los Ríos, Cristóbal, et al.
Publicado: (2023)

Gamma-Carbolines Derivatives As Promising Agents for the Development of Pathogenic Therapy for Proteinopathy
por: Skvortsova, V. I., et al.
Publicado: (2018)

The Promise and the Reality of Stem-Cell Therapies for Neurodegenerative Diseases
por: Glass, Jonathan D.
Publicado: (2010)

Commentary on “The Promise and the Reality of Stem-Cell Therapies for Neurodegenerative Diseases”
por: Koliatsos, Vassilis E., et al.
Publicado: (2010)

Novel Multitarget Hydroxamic Acids with a Natural Origin CAP Group against Alzheimer’s Disease: Synthesis, Docking and Biological Evaluation
por: Neganova, Margarita, et al.
Publicado: (2021)

Monoterpenoid Epoxidiol Ameliorates the Pathological Phenotypes of the Rotenone-Induced Parkinson’s Disease Model by Alleviating Mitochondrial Dysfunction
por: Aleksandrova, Yulia, et al.
Publicado: (2023)

Chronic Administration of Non-Constitutive Proteasome Inhibitor Modulates Long-Term Potentiation and Glutamate Signaling-Related Gene Expression in Murine Hippocampus
por: Maltsev, Alexander, et al.
Publicado: (2023)

Exploring Molecular Targets for Mitochondrial Therapies in Neurodegenerative Diseases
por: Plascencia-Villa, Germán, et al.
Publicado: (2023)

Will Sirtuins Be Promising Therapeutic Targets for TBI and Associated Neurodegenerative Diseases?
por: Yang, Qianjie, et al.
Publicado: (2020)

Emerging Promise of Therapeutic Approaches Targeting Mitochondria in Neurodegenerative Disorders
por: Rahman, Md. Mominur, et al.
Publicado: (2023)

Design, Synthesis and Pharmacological Evaluation of Novel C(2),C(3)-Quinoxaline Derivatives as Promising Anxiolytic Agents
por: Maltsev, Dmitriy V., et al.
Publicado: (2022)

The Novel Role of PPAR Alpha in the Brain: Promising Target in Therapy of Alzheimer’s Disease and Other Neurodegenerative Disorders
por: Wójtowicz, Sylwia, et al.
Publicado: (2020)

Promising molecular targeted therapies in breast cancer
por: Munagala, Radha, et al.
Publicado: (2011)

Molecular Pharmacology and Pathology of Strokes
por: Sheu, Joen-Rong
Publicado: (2018)

Chaperone-Mediated Autophagy in Neurodegenerative Diseases: Molecular Mechanisms and Pharmacological Opportunities
por: Wang, Yi-Ting, et al.
Publicado: (2022)

Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine
por: Kovacs, Gabor G.
Publicado: (2016)

Pathogenic Tau Protein Species: Promising Therapeutic Targets for Ocular Neurodegenerative Diseases
por: Mishan, Mohammad Amir, et al.
Publicado: (2019)

From Rate-Limiting Enzyme to Therapeutic Target: The Promise of NAMPT in Neurodegenerative Diseases
por: Zhu, Yumeng, et al.
Publicado: (2022)

Targeting mitochondrial bioenergetics as a promising therapeutic strategy in metabolic and neurodegenerative diseases
por: Bhatti, Gurjit Kaur, et al.
Publicado: (2022)

Resveratrol: Multi-Targets Mechanism on Neurodegenerative Diseases Based on Network Pharmacology
por: Wang, Wenjun, et al.
Publicado: (2020)

Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes
por: Wang, Yumin, et al.
Publicado: (2023)

Neurodegenerative Diseases: Molecular Mechanisms and Therapies
por: Zhou, Zhi Dong, et al.
Publicado: (2023)

Transdifferentiation: a new promise for neurodegenerative diseases
por: Mollinari, Cristiana, et al.
Publicado: (2018)

Berberine: A Promising Treatment for Neurodegenerative Diseases
por: Cheng, Ziqian, et al.
Publicado: (2022)

The Challenges and the Promise of Molecular Targeted Therapy in Malignant Gliomas()
por: Wang, Hongxiang, et al.
Publicado: (2015)

Fucoxanthin: A Promising Phytochemical on Diverse Pharmacological Targets
por: Mumu, Mumtaza, et al.
Publicado: (2022)

Inflammation/bioenergetics-associated neurodegenerative pathologies and concomitant diseases: a role of mitochondria targeted catalase and xanthophylls
por: Filippov, Mikhail A., et al.
Publicado: (2020)

Molecular Analysis of L-Asparaginases for Clarification of the Mechanism of Action and Optimization of Pharmacological Functions
por: Pokrovskaya, Marina V., et al.
Publicado: (2022)

Calcium-permeable AMPA receptors: an underestimated pharmacological target for the therapy of brain pathologies
por: Gaidin, Sergei G., et al.
Publicado: (2023)

Promising Molecular Targets for the Targeted Therapy of Biliary Tract Cancers: An Overview
por: Yang, Wenwei, et al.
Publicado: (2021)

Neuroplasticity in the Pathology of Neurodegenerative Diseases
por: Dorszewska, Jolanta, et al.
Publicado: (2020)

Platelets’ Nanomechanics and Morphology in Neurodegenerative Pathologies
por: Strijkova, Velichka, et al.
Publicado: (2022)

Neurodegenerative pathways as targets for acquired epilepsy therapy development
por: Casillas‐Espinosa, Pablo M., et al.
Publicado: (2020)

Biomaterials in Neurodegenerative Disorders: A Promising Therapeutic Approach
por: Bordoni, Matteo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_phmcb45b3o996ecm0upboa46i9